|
Dear Colleagues,
You are invited to a scientific presentation, "Patient iPSC-based NAM Platform for Precision Medicine in Congenital Heart Disease," by Dr. Mingtao Zhao on October 12 at 11:00 a.m. Personnel from all research pillars are welcome to attend. This event will be held both in-person and virtually.
Presenter: Mingtao Zhao, DVM, PhD
Principal Investigator, Center for Cardiovascular Research, Nationwide Children's Hospital
Director of Human iPSC Core and Faculty Director of Molecular Cellular Medicine Research Affinity Group, Abigail Wexner Research Institute, Nationwide Children's Hospital
Associate Professor (Molecular, Cellular and Developmental Biology), Department of Pediatrics, The Ohio State University
Dr. Zhao's research is focused on using patient-specific induced pluripotent stem cells (iPSCs) and genomic tools to investigate cellular and molecular aspects of congenital heart disease for novel diagnostic tool discovery and therapeutic development.
Presentation Title: Patient iPSC-based NAM Platform for Precision Medicine in Congenital Heart Disease
Date and Time: October 12, 11:00 a.m.–noon
In-Person Location: Simpson-Querrey Auditorium (SQBRC 1-230), Simpson Querrey Biomedical Research Center, 303 East Superior St.
Virtual Information: Via Zoom
| 
